Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

COVID19 (SARS-CoV2) vaccination/vaccine

5

XII.d Myocarditis (can be fulminant)

2

See PMID 34514306

Last update : 04/03/2022
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Myocarditis post-SARS-CoV-2 vaccination: a systematic review.
QJM : monthly journal of the Association of Physicians 2023 Feb 14;116;7-25 2023 Feb 14
Post-vaccine COVID-19 acute myocarditis: case reports and literature review.
The Pan African medical journal 2023;44;192 2023
Myocarditis Following COVID-19 Vaccination: A Systematic Review (October 2020-October 2021).
Heart, lung & circulation 2022 Jun;31;757-765 2022 Jun
A report of two cases of myocarditis following mRNA coronavirus disease 2019 vaccination.
European heart journal. Case reports 2022 Jan;6;ytac004 2022 Jan
Fulminant myocarditis after the second dose of COVID-19 mRNA vaccination.
Clinical case reports 2022 Feb;10;e05378 2022 Feb
Transient Myopericarditis Following Vaccination for COVID-19.
Journal of medical cases 2022 Feb;13;80-84 2022 Feb
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.
Vaccine 2022 Aug 19;40;5153-5159 2022 Aug 19
A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination.
Journal of Korean medical science 2022 Apr 04;37;e104 2022 Apr 04
Myocarditis following rAd26 and rAd5 vector-based COVID-19 vaccine: case report.
ESC heart failure 2022 Apr;9;1483-1486 2022 Apr
Myocarditis following COVID-19 mRNA vaccination.
Proceedings (Baylor University. Medical Center) 2022;35;209-213 2022
Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients.
International journal of cardiology 2021 Oct 01;340;119-121 2021 Oct 01
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines.
JAMA cardiology 2021 Oct 01;6;1115-1117 2021 Oct 01
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.
JAMA cardiology 2021 Oct 01;6;1196-1201 2021 Oct 01
Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines?
BMJ (Clinical research ed.) 2021 Jun 24;373;n1635 2021 Jun 24
First Report of Acute Myocarditis Post-Pfizer-BioNTech COVID-19 Vaccination in the Kingdom of Bahrain.
Cureus 2021 Dec;13;e20313 2021 Dec
Myocarditis After BNT162b2 and mRNA-1273 Vaccination.
Circulation 2021 Aug 10;144;506-508 2021 Aug 10
Myocarditis With COVID-19 mRNA Vaccines.
Circulation 2021 Aug 10;144;471-484 2021 Aug 10
Acute myocarditis following administration of BNT162b2 vaccine.
IDCases 2021;25;e01197 2021
COVID-19 mRNA Vaccine and Myocarditis.
European journal of case reports in internal medicine 2021;8;002681 2021
Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis.
Frontiers in cardiovascular medicine 2021;8;769616 2021

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies